Why read.
In this eye-opening piece, a battle-tested ortho medtech leader—who's championed H-1B hires from India, China, and Malaysia for their unmatched smarts and grit—unpacks how Trump's new $100K visa fee could cripple U.S. innovation in orthopedic devices, forcing startups to ditch global talent amid a booming market and risk exporting breakthroughs to friendlier shores.
My personal story
I am pro H-1B. In my career I hired three employees from India, China and Malaysia - the process wasn't easy, alot of paperwork and expenses but all three hires were excellent, very smart and outworked m...
